Shire Voluntarily Withdraws Daytrana Patches After Enhancing Adhesive
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm’s decision comes after patients and caregivers experienced difficulty removing the release liner from some Daytrana patches.
You may also be interested in...
Daytrana Manufacturing Woes Continue With FDA Warning Letter
Jan. 9 warning letter cites manufacturing deficiencies related to the transdermal ADHD patch.
Daytrana Manufacturing Woes Continue With FDA Warning Letter
Jan. 9 warning letter cites manufacturing deficiencies related to the transdermal ADHD patch.
A Sticky Situation For Shire’s Daytrana Patch, ISMP Reports
Shire will address adhesion issue following complaints that the adhesive for the patches sticks to the protective lining.